In breast cancer, an increase in Tregs population both in peripheral blood and tumor tissues was also reported [25] and a recent study demonstrated a significant intratumoral infiltration of FOXP3+ Tregs in high-risk breast cancer patients and those at risk of late relapse [26]. Here, FOXP3 is linked to neoplasm.